For this reason, we conducted an observational, retrospective, multicentre, casecontrol study to add more evidence to the results of the pilot study
Who is suitable for this treatment
Inflammatory subtype: This subtype is characterized by the absence of folliculitis/comedones and by the presence of abscesses and thick fistular tracts that show confluence in poorly defined inflammatory and scarring plaques
Neurohormonal Support & Mood Stabilization: Tesofensine works synergistically with methylated B6, B12, Folate, and Alpha-GPC to support dopaminergic and serotonergic pathways, enhancing mental clarity, mood balance, and stress resilience
Initially, only those with the highest clinical need will be prioritised to receive the medication while the NHS tests a variety of new services to care for people living with obesity. Following a consultation held in October on NHS Englands request to roll out the medication over 12 years, NICE has published its guidance on the way forward